home / stock / raonf / raonf quote
Last: | $1.22 |
---|---|
Change Percent: | 0.0% |
Open: | $1.22 |
Close: | $1.22 |
High: | $1.22 |
Low: | $1.22 |
Volume: | 8,000 |
Last Trade Date Time: | 07/11/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.22 | $1.22 | $1.22 | $1.22 | $1.22 | 8,000 | 07-11-2024 |
$0.83 | $0 | $0.83 | $0 | $0 | 261 | 08-14-2023 |
$0.83 | $0 | $0.83 | $0 | $0 | 3 | 08-11-2023 |
$0.83 | $0.83 | $0.83 | $0.83 | $0.83 | 499 | 07-26-2023 |
$1.45 | $1.45 | $1.45 | $1.45 | $1.45 | 2,800 | 07-04-2022 |
$1.45 | $1.45 | $1.45 | $1.45 | $1.45 | 2,800 | 07-01-2022 |
$2.6 | $2.6 | $2.6 | $2.6 | $2.6 | 1,150 | 11-01-2021 |
$2.5 | $2.5 | $2.5 | $2.5 | $2.5 | 780 | 10-27-2021 |
$2.39 | $2.39 | $2.39 | $2.39 | $2.39 | 780 | 10-05-2021 |
$2.6 | $2.6 | $2.6 | $2.6 | $2.6 | 300 | 09-29-2021 |
$2.69 | $2.69 | $2.69 | $2.69 | $2.69 | 8,000 | 07-16-2021 |
News, Short Squeeze, Breakout and More Instantly...
Race Oncology Company Name:
RAONF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Race Oncology Ltd (ASX:RAC, OTC:RAONF) CEO Dr Daniel Tillett joins Proactive’s Jonathan Jackson to discuss promising preclinical findings. Research indicated that combining bisantrene with decitabine greatly enhances the destruction of cancer cells across a wide variety of...
(NewsDirect) Race Oncology Ltd (ASX:RAC) CEO Daniel Tillett joins Jonathan Jackson in the Proactive studio to provide an update on the company’s movements over the last few months. Just recently, Race received a $4 million R&D tax incentive tto accelerate clinical development of bi...
(NewsDirect) Race Oncology Ltd (ASX:RAC) executive director Pete Smith speaks with Proactive alongside the company’s recently appointed CEO - 25-year veteran of the biotech space, Dr Daniel Tillett. In this pivotal role, Dr Tillett will work closely with Dr Smith to steer the company's...